Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medtronic, CardioMems go to panel
You may also be interested in...
Regulatory News In Brief
The latest on user fee negotiations and other device regulatory issues.
Regulatory News In Brief
Regulatory reform plans
St. Jude: CardioMEMS’ Heart Failure Data Reflects Major Opportunity
With the publication of the CHAMPION clinical trial results, CardioMEMS and its suitor St. Jude Medical took another step toward leading the pack in what they say is a multi-billion dollar market opportunity in hemodynamic heart failure monitoring.